2024 annual financial data
Autolus Therapeutics 2024 Operating margin
Direct answer
Operating margin was -2,385.63%.
Operating income was -241.43M USD and net income was -220.66M USD.
Operating cash flow was -206.27M USD.
Get free Autolus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10.12M USD
- Operating income
- -241.43M USD
- Net income
- -220.66M USD
- Operating cash flow
- -206.27M USD